South Korea
· Delayed Price · Currency is KRW Humasis Company Description
Humasis Co. Ltd. manufactures and sells pharmaceuticals and medical devices in South Korea and internationally.
It offers immunodiagnostic kits, such as quantitative and qualitative tests, cardiac and cancer markers, infectious diseases, hormones, and women’s health.
The company also provides bio-material products, such as COVID-19 nucleocapsid protein, human immunodeficiency virus surface proteins, COVID-19 RT-PCR kit, and COVID-19 Variant RT-qPCR kit, as well as MPXV real time PCR kit, a real-time polymerase chain reaction assay for the qualitative detection of nucleic acid from Monkeypox virus.
In addition, it offers diagnostic equipment, such as urinalysis, blood glucose meters, and immunodiagnostics tools.
Further, it provides other test kits, such as Cotinine to test cotinine in urine; and G6PD, an in vitro diagnostic test that can detect glucose-6-phosphate dehydrogenase in human whole blood.
The company was founded in 2000 and is headquartered in Anyang-si, South Korea.
| Country | South Korea |
| Founded | 2000 |
| Industry | In Vitro and In Vivo Diagnostic Substances |
| Employees | 105 |
| CEO | Sung-gon Kim |
Contact Details
Address: Hogye-dong, Shinwon Vision Tower Anyang-si, 14042 South Korea | |
| Phone | 82 31 8085 6200 |
| Website | humasis.com |
Stock Details
| Ticker Symbol | 205470 |
| Exchange | KOSDAQ |
| Fiscal Year | January - December |
| Reporting Currency | KRW |
| SIC Code | 2835 |
Key Executives
| Name | Position |
|---|---|
| Sung-gon Kim | Chief Executive Officer |